Aggressive Treatment Seen to Help Advanced Follicular Lymphoma Patients in Phase 2 Trial
News
Sequential chemoimmunotherapy, radioimmunotherapy, and maintenance treatment with Rituxan (rituximab) improves progression-free survival and delays disease progression in patients with untreated advanced follicular lymphoma, Phase 2 clinical trial data shows. The study reporting ... Read more